XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Valuation Assumptions The following principal inputs were used in the valuation of awards issued for the nine months ended September 30, 2023 and 2022:
Nine Months Ended September 30,
 20232022
Expected volatility
88.8%85.8%
Expected term (years)
5.5-6.5
5.5-6.5
Risk-free interest rate
3.4%3.3%
Expected dividend yield
0%0%
Value of underlying share
$0.36$0.43
Schedule of Stock Option Activity
Detail of the number of stock options outstanding for the nine months ended September 30, 2023 under the Company's 2015 legacy option plan and the Company's amended 2018 long term incentive plan (collectively, the "Plans") is as follows:
 
Number of Options
Weighted-
Average
Exercise
Price
per Option
Weighted-
Average
Remaining
Contract
Term

(in years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2022
3,957,027$1.528.37$46,800
Granted
3,748,6710.38
Exercised
Forfeited (and expired)
(1,170,291)1.38
Outstanding as of September 30, 2023
6,535,407$0.818.76$90,010
Exercisable/vested as of September 30, 2023
2,745,812$1.177.49$
Schedule of Restricted Stock
Details of the number of restricted share units outstanding under the 2018 Plan is as follows:
 
Number of Shares
Weighted-
Average
Grant Date Fair Value
Outstanding as of December 31, 2022
2,569,574$0.98
Granted
3,598,076$0.27
Forfeited
(436,785)$1.22
Vested
(1,644,830)$0.70
Shares withheld upon vesting
(526,266)$0.77
Outstanding as of September 30, 2023
3,559,769$0.39